LINDA MOODY: Open Payments
NPI 1235634361 · BRISTOL, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$621 in 27 payments from 8 companies in 2025. Trend: 2023 $490 · 2024 $515 · 2025 $621
Food & beverage: $621
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 6 | $153 |
| Merck Sharp & Dohme LLC | 6 | $110 |
| ABBVIE INC. | 5 | $98 |
| Shionogi Inc | 1 | $97 |
| Insmed, Inc. | 3 | $69 |
| La Jolla Pharmaceutical Company | 3 | $46 |
| ViiV Healthcare Company | 2 | $31 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
Products named: Epclusa, ZERBAXA, Fetroja, Arikayce, EMBLAVEO, DALVANCE, ZEVTERA, AVYCAZ.
Industry payments across TN — which companies pay providers there.
